FAM222A Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-24832
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody has been engineered to specifically recognize the recombinant protein FAM222A using the following amino acid sequence: QPLRAYSGSTVASKSPEACGGRAYERASGSPLNCGVGLPTSFTVGQYFAAPWNSVLVTPTSDCYNPA
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for FAM222A Antibody
Immunocytochemistry/Immunofluorescence: FAM222A Antibody [NBP3-24832]
Staining of human cell line MCF-7 shows localization to the Golgi apparatus & cell junctions.Applications for FAM222A Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 µg/ml
Application Notes
For ICC/IF, we recommend using a combination of PFA and Triton X-100. This will give you the optimal results for your experiments.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, pH 7.2, 40% glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: FAM222A
Alternate Names
C12orf34, chromosome 12 open reading frame 34, FLJ14721, hypothetical protein LOC84915
Gene Symbol
FAM222A
Additional FAM222A Products
Product Documents for FAM222A Antibody
Product Specific Notices for FAM222A Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...